Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma
RSC Pharmaceutics · 2024 · 1 (3) · 548-569
DOI: 10.1039/d4pm00031e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2024. Verfasst von B. N. Kumara und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Lysozyme, the enzyme found in tears, activates delivery of the anti-glaucoma drugs latanoprost and timolol from mucoadhesive chitosan nanocomposites through the cleavage of β-1,4 glycosidic bonds.
Förderung
- Science and Engineering Research Board
Zitieren
APA
Kumara, B. N., Shambhu, R., Shim, Y., & Prasad, K. S. (2024). Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma. RSC Pharmaceutics, 1(3), 548-569. https://doi.org/10.1039/d4pm00031e
Vancouver
Kumara BN, Shambhu R, Shim Y, Prasad KS. Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma. RSC Pharmaceutics. 2024;1(3):548-569. doi:10.1039/d4pm00031e
BibTeX
@article{Kumara2024,
author = {Kumara, B. N. and Shambhu, R. and Shim, Yoon-Bo and Prasad, K. Sudhakara},
title = {Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma},
journal = {RSC Pharmaceutics},
year = {2024},
volume = {1},
number = {3},
pages = {548--569},
doi = {10.1039/d4pm00031e}
}
EUVIMED